Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 12, Number 3—March 2006
Letter

"Mycobacterium tilburgii" Infections

Dirk Wagner*Comments to Author , Margreet C. Vos†‡, Anton G.M. Buiting‡, Annerose Serr*, Anneke M.C. Bergmans§, Winfried Kern*, and Leo M. Schouls¶
Author affiliations: *University Hospital, Freiburg, Germany; †Erasmus University Medical Center, Rotterdam, the Netherlands; ‡St Elisabeth Hospital, Tilburg, the Netherlands; §Franciscus Hospital, Roosendaal, the Netherlands; ¶National Institute of Public Health and the Environment, Bilthoven, the Netherlands

Main Article

Table

Characteristics of patients with confirmed "Mycobacterium tilburgii" disease*

Sex (age, y) Immuno-suppression CD4 count (cell/μL) Disease manifestation Treatment (duration, mo) Diagnosed in Reference
F (45) No Normal Bladder, intestinal lymphnodes, stomach, ileum, colon Pyrazinamide, isoniazid, rifampin (5); ethambutol, ciprofloxacin, clarithromycin, rifampin (11); surgical resection The Netherlands This study
M (34) AIDS 37 Esophagus, duodenum Ethambutol, clarithromycin, rifabutin (5) Germany This study
M (35) AIDS 20 Duodenum, abdominal lymph nodes Ethambutol, clarithromycin, rifabutin (12†) Germany (9)
M (41) AIDS 17 Pulmonary nodules Surgical resection; ethambutol, ciprofloxacin, clarithromycin (6); ethambutol, clarithromycin (12‡) Germany (10)

Main Article

References
  1. Brown-Elliott  BA, Griffith  DE, Wallace  RJ Jr. Newly described or emerging human species of nontuberculous mycobacteria. Infect Dis Clin North Am. 2002;16:187–220. DOIPubMedGoogle Scholar
  2. Wagner  D, Young  LS. Nontuberculous mycobacterial infections. Infection. 2004;32:257–70. DOIPubMedGoogle Scholar
  3. Kirschner  P, Springer  B, Vogel  U, Meier  A, Wrede  A, Kiekenbeck  M, Genotypic identification of mycobacteria by nucleic acid sequence determination: report of a 2-year experience in a clinical laboratory. J Clin Microbiol. 1993;31:2882–9.PubMedGoogle Scholar
  4. Buiting  A, Vos  M, Bergmans  A, Schouls  L. A new mycobacterial species causing disseminated infection. 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco 1995; Abstract K45. Washington: American Society for Microbiology; 1995.
  5. Realini  L, De  RK, Hirschel  B, Portaels  F. Blood and charcoal added to acidified agar media promote the growth of Mycobacterium genavense. Diagn Microbiol Infect Dis. 1999;34:45–50. DOIPubMedGoogle Scholar
  6. Selvarangan  R, Wu  WK, Nguyen  TT, Carlson  LD, Wallis  CK, Stiglich  SK, Characterization of a novel group of mycobacteria and proposal of Mycobacterium sherrisii sp. nov. J Clin Microbiol. 2004;42:52–9. DOIPubMedGoogle Scholar
  7. Wayne  LG, Good  RC, Bottger  EC, Butler  R, Dorsch  M, Ezaki  T, Semantide- and chemotaxonomy-based analyses of some problematic phenotypic clusters of slowly growing mycobacteria, a cooperative study of the International Working Group on Mycobacterial Taxonomy. Int J Syst Bacteriol. 1996;46:280–97. DOIPubMedGoogle Scholar
  8. Hughes  MS, James  G, Ball  N, Scally  M, Malik  R, Wigney  DI, Identification by 16S rRNA gene analyses of a potential novel mycobacterial species as an etiological agent of canine leproid granuloma syndrome. J Clin Microbiol. 2000;38:953–9.PubMedGoogle Scholar
  9. Richter  E, Rusch-Gerdes  S, Niemann  S, Stoehr  A, Plettenberg  A. Detection, identification, and treatment of a novel, non-cultivable Mycobacterium species in an HIV patient. AIDS. 2000;14:1667–8. DOIPubMedGoogle Scholar
  10. Kolditz  M, Halank  M, Spornraft-Ragaller  P, Schmidt  H, Höffken  G. Localized pulmonary infection associated with Mycobacterium tilburgii in an HIV-infected patient. Infection. 2005;33:278–81. DOIPubMedGoogle Scholar

Main Article

Page created: January 27, 2012
Page updated: January 27, 2012
Page reviewed: January 27, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external